Nitazoxanide for chronic hepatitis C
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Nitazoxanide for Chronic Hepatitis C." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432652/all/Rofecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed 28 March 2024.
Nitazoxanide for chronic hepatitis C. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432652/all/Rofecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed March 28, 2024.
Nitazoxanide for chronic hepatitis C. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432652/all/Rofecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review
Nitazoxanide for Chronic Hepatitis C [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432652/all/Rofecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nitazoxanide for chronic hepatitis C
ID - 432652
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432652/all/Rofecoxib_for_rheumatoid_arthritis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -